NCT06346522View on ClinicalTrials.gov

Gabapentin Versus Trospium Chloride for Prevention of a Catheter-related Bladder Discomfort Inside the ICU

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

September 20, 2024

Conditions
Catheter-related Bladder Discomfort (CRBD)
Interventions
DRUG

Gabapentin (Gaptin ®) 400mg oral capsule once

After the patient will regain feeding, the patients will take with sips of water Gabapentin (Gaptin ®) 400mg oral capsule once in the first 24 hour after icu admission

DRUG

Trospium chloride slow release (Trospikan ® SR) 60mg oral capsule

After the patient will regain feeding, the patients will take with sips of water Trospium chloride slow release (Trospikan ® SR) 60mg oral capsule once in the first 24 hour after icu admission

Trial Locations (1)

Unknown

Ain Shams University-Faculty of Medicine, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06346522 - Gabapentin Versus Trospium Chloride for Prevention of a Catheter-related Bladder Discomfort Inside the ICU | Biotech Hunter | Biotech Hunter